Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 11Rhabdomyosarcoma 7Sarcoma, Ewing 4Osteosarcoma 4Sarcoma, Synovial 3Neurofibrosarcoma 3Lymphoma, Large B-Cell, Diffuse 3Dendritic Cell Sarcoma, Interdigitating 3Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Fibrosarcoma 2Bone Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Recurrent Uterine Corpus Sarcoma 1Ovarian Neoplasms 1Neutropenia 1Neoplasms 1Neoplasm Metastasis 1Malignant mesenchymal tumor 1Hemangiosarcoma 1Heart Failure 1Gliosarcoma 1Glioma 1Glioblastoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1

Interventions

Ibandronic Acid 8Gemcitabine 8Doxorubicin 6Cyclophosphamide 6Zoledronic Acid 5Radiation 4Nivolumab 4Irinotecan 4pembrolizumab 3Vincristine 3Temozolomide 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Docetaxel 3Denosumab 3Cisplatin 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3regorafenib 2pegfilgrastim 2Tranexamic Acid 2Trabectedin 2Surveys and Questionnaires 2Sunitinib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiosurgery 2Quality of Life 2Proton Therapy 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Neoplasms × pegfilgrastim × Sarcoma × Clear all
NCT01313884 2017-11-24

Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma

Stanford University

Phase 2 Terminated
3 enrolled 7 charts
Sarcoma

Bone Neoplasms, Sarcoma, Ewing

NCT00035620 2010-02-26

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy

Amgen

Phase 2 Completed
44 enrolled
Sarcoma

Bone Neoplasms, Neutropenia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡